Literature DB >> 26917612

An overview on tuberculosis-specific hospitals in China in 2009: results of a national survey.

Yu Pang1, Jian Du2, Zhi Zhen Qin3, Zoë Greenwald4, Yuhong Liu5, Fengling Mi5, Yanlin Zhao6, Liang Li7.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26917612     DOI： 10.1183/13993003.01854-2015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  8 in total

1.  In Vitro Drug Susceptibility of Bedaquiline, Delamanid, Linezolid, Clofazimine, Moxifloxacin, and Gatifloxacin against Extensively Drug-Resistant Tuberculosis in Beijing, China.

Authors:  Yu Pang; Zhaojing Zong; Fengmin Huo; Wei Jing; Yifeng Ma; Lingling Dong; Yunxu Li; Liping Zhao; Yuhong Fu; Hairong Huang
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

2.  Development and validation of external quality assessment panels for mycobacterial culture testing to diagnose tuberculosis in China.

Authors:  Jian Du; Wei Shu; Yuhong Liu; Yufeng Wang; Ying Zhan; Kexin Yu; Jingtao Gao; Liang Li; Yu Pang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-07-24       Impact factor: 3.267

3.  Multicenter feasibility study to assess external quality panels for molecular diagnostics for tuberculosis in China.

Authors:  Jian Du; Wei Shu; Yuhong Liu; Yufeng Wang; Ying Zhan; Kexin Yu; Jingtao Gao; Liang Li; Yu Pang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-03       Impact factor: 3.267

4.  External quality control of phenotypic drug susceptibility testing for Mycobacterium tuberculosis in China.

Authors:  Wei Shu; Jian Du; Yuhong Liu; Yufeng Wang; Fengmin Huo; Guanglu Jiang; Liang Li; Yu Pang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-02       Impact factor: 3.267

5.  An Overview of Tuberculosis-Designated Hospitals in China, 2009-2015: A Longitudinal Analysis of National Survey Data.

Authors:  Yuhong Liu; Yu Pang; Jian Du; Wei Shu; Yan Ma; Jingtao Gao; Lijie Zhang; Shaofa Xu; Liang Li
Journal:  Biomed Res Int       Date:  2019-08-20       Impact factor: 3.411

6.  Rapid Diagnosis Of Multidrug-Resistant Tuberculosis Impacts Expenditures Prior To Appropriate Treatment: A Performance And Diagnostic Cost Analysis.

Authors:  Xuezheng Li; Yunfeng Deng; Junling Wang; Hui Jing; Wei Shu; Jingmin Qin; Yu Pang; Xin Ma
Journal:  Infect Drug Resist       Date:  2019-11-14       Impact factor: 4.003

7.  Additional benefits of GeneXpert MTB/RIF assay for the detection of pulmonary tuberculosis patients with prior exposure to fluoroquinolones.

Authors:  Peijun Tang; Ping Xu; Wei Shu; Xiafang Wang; Jian Guo; Huafeng Song; Sumei Li; Yu Pang; Meiying Wu
Journal:  Infect Drug Resist       Date:  2018-12-27       Impact factor: 4.003

8.  Prevalence and risk factors of pulmonary nontuberculous mycobacterial infections in the Zhejiang Province of China.

Authors:  Jintian Xu; Ping Li; Shengchao Zheng; Wei Shu; Yu Pang
Journal:  Epidemiol Infect       Date:  2019-09-11       Impact factor: 2.451
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.